compound
TB-500 (5mg Vial) Questions Answered
TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] .
TB-500 (5mg Vial)
Phase Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 500 mcg 30 units (0.30 mL) Weeks 3–4 600 mcg 36 units (0.36 mL) Weeks 5–8 750 mcg 45 units (0.45 mL) Weeks 9–12 1000 mcg 60 units (0.60 mL) Frequency: Inject once daily subcutaneously.
TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] .
Phase Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 500 mcg 30 units (0.30 mL) Weeks 3–4 600 mcg 36 units (0.36 mL) Weeks 5–8 750 mcg 45 units (0.45 mL) Weeks 9–12 1000 mcg 60 units (0.60 mL) Frequency: Inject once daily subcutaneously.
Plan based on an 8–16 week daily protocol with gradual titration. Peptide Vials (TB‑500, 5 mg each): 8 weeks ≈ 8 vials 12 weeks ≈ 12 vials 16 weeks ≈ 16 vials Insulin Syringes (U‑100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes...
Practical considerations for consistency and safety in research protocols. Use new sterile insulin syringes for each injection; dispose in a sharps container.